ClinicalTrials.gg
Active, not recruitingNCT06904469Updated Aug 20, 2025

Ostrobothnia Digital Clinic Experiment

An interventional study of Access to a digital clinic in Primary Care Provider, sponsored by Finnish Institute for Health and Welfare. Active, not recruiting at 1 site in Finland. Per ClinicalTrials.gov, last updated 2025-08-20.

Sponsored by Finnish Institute for Health and Welfare · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Primary completion was expected by Jan 2026, 9 months ago, but the record still lists the study as active, not recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
170,306
Allocation
Randomized
Sex
All
01

Study summary

This randomized controlled trial (RCT) examines the impacts of a publicly provided digital clinic that offers digital primary care services to consumers. This intervention grants access to a public digital clinic that provides chat-based primary care consultations via a mobile phone application and website, including care needs assessment, diagnoses, follow-up care recommendations, and prescriptions. The digital clinic supplements traditional public primary care services, including in-person visits and phone consultations. The trial takes place in Ostrobothnia, Finland, a healthcare district serving a population of 178,000 residents. The investigators will randomize access to the digital clinic at the household level, providing access to 50% of the households. By doing so, the investigators aim to evaluate whether digital services can substitute for, complement, or increase the utilization of traditional primary care, particularly in-person visits or calls to traditional clinics. At the end of the nine-month trial, access to the digital clinic will be expanded to the entire population.

02

Conditions studied

  • Primary Care Provider

Keywords

  • digital healthcare
  • telemedicine
  • digital clinic
  • primary care
  • healthcare utilization
  • randomized controlled trial
03

In context

Lead sponsor

Finnish Institute for Health and Welfare is the lead sponsor of 42 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria for the intervention:

  • All residents alive and residing in the region of Ostrobothnia (Finland) on March 14, 2015, AND permanent address observed in the Finnish Population Information System

Exclusion Criteria for the intervention:

  • Resides in the city of Kristiinankaupunki OR resides in a household defined as institutionalized care

Exclusion Criteria for the analysis sample:

  • The inclusion and exclusion criteria mentioned above AND:
  • If an individual from the target population, extracted from the Population Information System, is not observed in Statistics Finland datasets, which is defined as not having a municipality of residence (missing data) at the end of 2024, the investigators will not use that individual in the study population in the analyses because the data do not include have covariates for the individual.
  • Age 71 and above
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
170,306 participants (estimated)

Study arms

  • Experimental
    Access to a digital clinic

    Access to a digital clinic, which offers assessments, diagnoses, follow-up care recommendations, and prescriptions

    Other: Access to a digital clinic

  • No intervention
    No access to a digital clinic (treatment as usual)

    Health care as usual without access rights to a digital clinic

Interventions

  • OtherAccess to a digital clinic

    This intervention grants access to a digital clinic that provides chat-based primary care consultations via phone application and website.

06

What researchers measure

Primary outcomes

  1. The number of in-person visits in public primary care (Y1.1)

    This outcome includes in-person visits to nurses and physicians in traditional public primary care clinics.

    Time frame: From the digital clinic launch to the end of treatment at 9 months

Secondary outcomes

  1. The number of other contacts with traditional public primary care (Y1.2)

    This outcome includes care needs assessments, remote appointments to nurses and physicians, and professional-to-professional interactions between nurses and physicians in traditional public primary care clinics.

    Time frame: From the digital clinic launch to the end of treatment at 9 months

  2. The number of public digital clinic contacts (D.1).

    This outcome includes care needs assessments, remote appointments to nurses and physicians (via chat and video), and professional-to-professional interactions between nurses and physicians in digital public primary care clinics.

    Time frame: From the digital clinic launch to the end of treatment at 9 months

Other outcomes

  1. The total number of public primary care contacts (Y1.3)

    This outcome includes in-person visits to nurses and physicians, care needs assessments, remote appointments to nurses and physicians, and professional-to-professional interactions between nurses and physicians in digital and traditional public primary care clinics.

    Time frame: From the digital clinic launch to the end of treatment at 9 months

  2. Presence or absence of public digital clinic contacts during the follow-up (yes/no) (D.2).

    This outcome includes care needs assessments, remote appointments to nurses and physicians (via chat and video), and professional-to-professional interactions between nurses and physicians in digital public primary care clinics. This outcome is 1 if the person has at least one contact with the public digital clinic during follow-up and 0 if the person has no contact during follow-up.

    Time frame: From the digital clinic launch to the end of treatment at 9 months

07

Study locations

1 site
  • Wellbeing Services County of Ostrobothnia
    Vaasa, Finland
08

References and documents

Individual participant data

Plan to share: No — The dataset containing individual-level health data and demographic data is regulated under the Act on the Secondary Use of Health and Social Data (552/2019) and cannot be made readily available for the purpose of direct replication. However, access to the data can be obtained by sending requests to the Finnish Social and Health Data Permit Authority, Findata, and to Statistics Finland. The investigators commit to publishing all statistical code and other details of the computations that are sufficient to permit the validation of empirical work. The investigators commit to storing the treatment assignment code and data for future use, allowing interested researchers to construct the full dataset required for further research utilizing the original treatment assignment.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Apr 2025 (actual). Primary completion is estimated for Jan 2026, 8 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 18, 2025
First posted
Apr 1, 2025
StartActual
Apr 15, 2025
Primary completionEst.
Jan 14, 2026
CompletionEst.
Jan 14, 2026
Last update
Aug 20, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 20, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06904469
Lead sponsor
Finnish Institute for Health and Welfare
Collaborators
Aalto University, University of Turku
Responsible party
Lauri Sääksvuori (Principal investigator, Finnish Institute for Health and Welfare) — Principal investigator
First posted
Apr 1, 2025
Start date
Apr 15, 2025
Primary completion
Jan 14, 2026 (estimated)
Completion
Jan 14, 2026 (estimated)
Last update
Aug 20, 2025

Study contacts

Mika T Kortelainen, PhD
study director · University of Turku and Finnish Institute for Health and Welfare

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion